These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 157647)

  • 1. [Beta-pyridyl-carbinol in the treatment of hyperlipoproteinemia].
    Kleiber G; Leickert KH
    ZFA (Stuttgart); 1979 Jul; 55(21):1199-205. PubMed ID: 157647
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hypercholesterolemia with beta-pyridylcarbinol. Experiences after long term treatment over 8 years (author's transl)].
    Zöllner N; Keller C; Wolfram G
    Med Klin; 1976 Apr; 71(18):768-74. PubMed ID: 818496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R; Müller A; Klose G; Middelhoff G; Augustin J; Haase W; Greten H
    MMW Munch Med Wochenschr; 1978 Apr; 120(15):525-8. PubMed ID: 206826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood levels and effectiveness of beta-pyridyl carbinol in a new controlled release form in subjects with healthy metabolism and in patients with hyperlipoproteinemia II].
    Schulz E; Schräpler P
    Ther Umsch; 1980 Feb; 37(2):137-43. PubMed ID: 7385082
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)].
    Wolfram G; Keller C; Kilani S; Zöllner N
    Dtsch Med Wochenschr; 1976 Jan; 101(3):76-81. PubMed ID: 1245160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of hypertriglyceridemia].
    Wollenweber J
    ZFA (Stuttgart); 1978 Feb; 54(6):349-53. PubMed ID: 636529
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of hypercholesterolemia with beta-pyridylcarbinol. Part 5. Report on 16 cases with severe hypercholesterolemia treated for 12 years.
    Zöllner N; Keller CH; Wolfram G
    Atherosclerosis; 1977 Apr; 26(4):611-5. PubMed ID: 856228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Liapten--a new lipid depressor. Clinical experience in lipid metabolism disorders].
    Fodor GP
    ZFA (Stuttgart); 1978 Jan; 54(1):49-55. PubMed ID: 622856
    [No Abstract]   [Full Text] [Related]  

  • 9. [STUDIES ON THE TREATMENT OF ENDOGENOUS HYPERLIPOPROTEINEMIA WITH BETA-PYRIDYL-CARBINOL].
    SCHOEN H; ZELLER W; HENNING N
    Klin Wochenschr; 1963 Nov; 41():1108-9. PubMed ID: 14109876
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical testing of Danaden retard in functional psychoses from the aspect of slight to medium severe transient syndrome].
    Engelmann G
    Med Welt; 1975 Jul; 26(29-30):1380-4. PubMed ID: 1100984
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of sound perception deafness with Danaden retard].
    Koeppel FW
    MMW Munch Med Wochenschr; 1976 Aug; 118(32-33):1015-6. PubMed ID: 822295
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment with high-dose beta-pyridylcarbinol: results in patients with hypercholesterinemia].
    Mordasini R; Schlumpf E; Nobile PC; Brun del Re G; Riva G
    Schweiz Med Wochenschr; 1978 Apr; 108(14):533-8. PubMed ID: 635510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the lipid-lowering effect of clofibrate, and of clofibrate plus beta-pyridylcarbinol.
    Graham L; Mulcahy R; Hickey N
    Atherosclerosis; 1977 Aug; 27(4):487-92. PubMed ID: 884003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and tolerance of a new sustained-release preparation of nicotinic alcohol for reduction of the atherosclerotic risk index].
    Bossini A; Pirro C; Barba C
    Clin Ter; 1984 Sep; 110(5):417-28. PubMed ID: 6238757
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug treatment of hypercholesterolemia. Experience with a combination of dextrothyroxine and betapyridylcarbinol (author's transel)].
    Schneider J; Schubotz R; Manteuffel Ev; Kaffarnik H
    Med Klin; 1978 Jun; 73(23):874-7. PubMed ID: 661731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of nicotinic acid, niceritrol and beta-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs.
    Lundholm L; Jacobsson L; Brattsand R; Magnusson O
    Atherosclerosis; 1978 Feb; 29(2):217-39. PubMed ID: 646851
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic activity of a combination of nicotinyl alcohol, vitamin A and vitamin E in atherosclerotic arteriopathies].
    Putignano G
    Clin Ter; 1980 Aug; 94(3):275-82. PubMed ID: 7449347
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood pharmacokinetics of fluorine in man after the oral administration of nicomethanol hydrofluoride].
    Cheymol G; Souleau M; Mahuzier G; Poitou P
    J Biol Buccale; 1984 Dec; 12(4):349-53. PubMed ID: 6597190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment possibilities of arterial circulatory disorders using calcitonin].
    Staehelin A
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1865-7. PubMed ID: 337477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of intermittent claudication with betapyridyl carbinol over two years.
    Nye ER; Macbeth WA
    Atherosclerosis; 1973; 17(1):95-106. PubMed ID: 4696751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.